A Prospective Multicenter Non-interventional Cohort Study on Patients'Satisfaction With Angeliq Micro in Real Clinical Practice Conducted in Russia
Latest Information Update: 25 Aug 2020
Price :
$35 *
At a glance
- Drugs Estradiol/drospirenone (Primary)
- Indications Menopausal syndrome; Vasomotor symptoms
- Focus Therapeutic Use
- Sponsors Bayer
- 21 Jun 2020 Status changed from active, no longer recruiting to completed.
- 23 Mar 2020 Planned End Date changed from 30 Apr 2020 to 31 May 2020.
- 30 Dec 2019 Status changed from recruiting to active, no longer recruiting.